Effectiveness of Netarsudil versus Brimonidine in Eyes already Being Treated with Glaucoma Medications at a Single Academic Tertiary Care Practice: A Comparative Study

• Main Authors: Alex T. Pham, BS (Author), Chris Bradley, PhD (Author), Corinne Casey, OD (Author), Henry D. Jampel, MD (Author), Pradeep Y. Ramulu, MD, PhD (Author), Jithin Yohannan, MD, MPH (Author)
• Format: Book
• Published: Elsevier, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACT: Background: Rho kinase inhibitors, such as netarsudil, are a relatively new class of medications recently introduced into the market for the treatment of glaucoma, the leading cause of irreversible blindness in the world. Previous clinical trials have studied netarsudil's efficacy whe...